Abstract
Purpose of Review
We sought to summarize the current evidence on use of intravascular imaging (with intravascular ultrasound [IVUS] or optical coherence tomography [OCT]) in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Recent Findings
Utilization of intravascular imaging in CTO PCI is increasing over time, both to facilitate CTO crossing and for optimization of the final result. OCT is used less often than IVUS due to its lower depth of penetration and need for contrast injection.
Summary
Intravascular imaging has multiple uses in CTO PCI: (a) it can facilitate CTO crossing by resolving proximal cap ambiguity and facilitating and confirming true lumen wire re-entry in case of initial subintimal wire crossing in both the antegrade and retrograde direction (for example by selecting the appropriate balloon size during the reverse controlled antegrade and retrograde tracking (reverse CART) technique; (b) it can be used to optimize the PCI result by ensuring good stent expansion and stent strut apposition, which may in turn result in lower rates of subsequent in-stent restenosis and stent thrombosis; (c) can facilitate evaluation and treatment of complications.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Galassi AR, Sianos G, Werner GS, Escaned J, Tomasello SD, Boukhris M, et al. Retrograde recanalization of chronic total occlusions in Europe: procedural, in-hospital, and long-term outcomes from the multicenter ERCTO registry. J Am Coll Cardiol. 2015;65(22):2388–400. https://doi.org/10.1016/j.jacc.2015.03.566.
Maeremans J, Walsh S, Knaapen P, Spratt JC, Avran A, Hanratty CG, et al. The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. J Am Coll Cardiol. 2016;68(18):1958–70. https://doi.org/10.1016/j.jacc.2016.08.034.
Morino Y, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, et al. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO registry (multicenter CTO registry in Japan). JACC Cardiovasc Interv. 2010;3(2):143–51. https://doi.org/10.1016/j.jcin.2009.10.029.
Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, et al. The hybrid approach to chronic total occlusion percutaneous coronary intervention: update from the PROGRESS CTO registry. JACC Cardiovasc Interv. 2018;11:1325–35. https://doi.org/10.1016/j.jcin.2018.02.036.
Wilson WM, Walsh SJ, Yan AT, Hanratty CG, Bagnall AJ, Egred M, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart. 2016;102(18):1486–93. https://doi.org/10.1136/heartjnl-2015-308891.
Arroyo-Ucar E, Moreno R, Garcia E, Teles R, Rumoroso JR, Carvalho HC, et al. Drug-eluting stent thrombosis in the treatment of chronic total coronary occlusions: incidence, presentation and related factors. Data from the CIBELES trial. Rev Port Cardiol. 2015;34(3):193–9. https://doi.org/10.1016/j.repc.2014.08.026.
Azzalini L, Demir OM, Gasparini GL, Grancini L, La Manna A, Ojeda S, et al. Outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent in patients with chronic total occlusions: a multicenter registry. Int J Cardiol. 2018;258:36–41. https://doi.org/10.1016/j.ijcard.2018.01.115.
Kandzari DE, Kini AS, Karmpaliotis D, Moses JW, Tummala PE, Grantham JA, et al. Safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: results from the EXPERT CTO multicenter trial (evaluation of the XIENCE coronary stent, performance, and technique in chronic total occlusions). JACC Cardiovasc Interv. 2015;8(6):761–9. https://doi.org/10.1016/j.jcin.2014.12.238.
• Karacsonyi J, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani J, et al. Use of intravascular imaging during chronic total occlusion percutaneous coronary intervention: insights from a contemporary multicenter registry. J Am Heart Assoc. 2016;5(8). https://doi.org/10.1161/JAHA.116.003890 This report from a multicenter US CTO PCI registry demonstrated 38% use of intravascular imaging during CTO PCI; intravascular imaging was used to facilitate crossing in 35.7% and for stent sizing and stent optimization in the remaining cases.
• Kim BK, Shin DH, Hong MK, Park HS, Rha SW, Mintz GS, et al. Clinical impact of intravascular ultrasound-guided chronic total occlusion intervention with zotarolimus-eluting versus biolimus-eluting stent implantation: randomized study. Circ Cardiovasc Interv. 2015;8(7):e002592. https://doi.org/10.1161/circinterventions.115.002592 This randomized-controlled trial of IVUS vs. angiographic guidance after CTO crossing demonstarted that IVUS-guided CTO intervention was associated with lower 12-month major adverse cardiac event rate (2.6% vs. 7.1%; p = 0.035).
• Tian NL, Gami SK, Ye F, Zhang JJ, Liu ZZ, Lin S, et al. Angiographic and clinical comparisons of intravascular ultrasound-versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention. 2015;10(12):1409–17. https://doi.org/10.4244/eijv10i12a245 This randomized-controlled trial of IVUS vs. angiographic guidance of stenting of CTO lesions demonstrated lower in-stent late lumen loss in the IVUS-guided group at one-year follow-up (0.28 ± 0.48 mm vs. 0.46 ± 0.68 mm, p = 0.025), as well as lower restenosis of the “in-true-lumen” stent (3.9% vs. 13.7%, p = 0.021).
Koganti S, Kotecha T, Rakhit RD. Choice of intracoronary imaging: when to use intravascular ultrasound or optical coherence tomography. Interv Cardiol (London, England). 2016;11(1):11–6. https://doi.org/10.15420/icr.2016:6:1.
Estevez-Loureiro R, Ghione M, Kilickesmez K, Agudo P, Lindsay A, Di Mario C. The role for adjunctive image in pre-procedural assessment and peri-procedural management in chronic total occlusion recanalisation. Curr Cardiol Rev. 2014;10(2):120–6.
Christakopoulos GE, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, et al. Contrast utilization during chronic total occlusion percutaneous coronary intervention: insights from a contemporary multicenter registry. J Invasive Cardiol. 2016;28(7):288–94.
Liu Y, Liu Y, Li H, Zhou Y, Guo W, Duan C, et al. Percutaneous coronary intervention for chronic total occlusion improved prognosis in patients with renal insufficiency at high risk of contrast-induced nephropathy. Sci Rep. 2016;6:21426. https://doi.org/10.1038/srep21426.
Sapontis J, Christopoulos G, Grantham JA, Wyman RM, Alaswad K, Karmpaliotis D, et al. Procedural failure of chronic total occlusion percutaneous coronary intervention: insights from a multicenter US registry. Catheter Cardiovasc Interv. 2015;85(7):1115–22. https://doi.org/10.1002/ccd.25807.
Alessandrino G, Chevalier B, Lefevre T, Sanguineti F, Garot P, Unterseeh T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion. JACC Cardiovasc Interv. 2015;8(12):1540–8. https://doi.org/10.1016/j.jcin.2015.07.009.
Karatasakis A, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, et al. Impact of proximal cap ambiguity on outcomes of chronic total occlusion percutaneous coronary intervention: insights from a multicenter US registry. J Invasive Cardiol. 2016;28(10):391–6.
• Harding SA, Wu EB, Lo S, Lim ST, Ge L, Chen JY, et al. A New Algorithm for Crossing Chronic Total Occlusions From the Asia Pacific Chronic Total Occlusion Club. JACC Cardiovasc Interv. 2017;10(21):2135–43. https://doi.org/10.1016/j.jcin.2017.06.071 Description of the Asia Pacific algorithm for CTO PCI crossing that advocates use of IVUS in cases with ambiguous proximal cap.
Galassi AR, Sumitsuji S, Boukhris M, Brilakis ES, Di Mario C, Garbo R, et al. Utility of intravascular ultrasound in percutaneous revascularization of chronic total occlusions: an overview. JACC Cardiovasc Interv. 2016;9(19):1979–91. https://doi.org/10.1016/j.jcin.2016.06.057.
Dautov R, Abdul Jawad Altisent O, Rinfret S. Stumpless chronic total occlusion with no retrograde option: multidetector computed tomography-guided intervention via bi-radial approach utilizing bioresorbable vascular scaffold. Catheter Cardiovasc Interv. 2015;86(6):E258–62. https://doi.org/10.1002/ccd.25938.
Ryan N, Gonzalo N, Dingli P, Cruz OV, Jimenez-Quevedo P, Nombela-Franco L, et al. Intravascular ultrasound guidance of percutaneous coronary intervention in ostial chronic total occlusions: a description of the technique and procedural results. Int J Cardiovas Imaging. 2017;33(6):807–13. https://doi.org/10.1007/s10554-017-1086-2.
Nakashima M, Ikari Y, Aoki J, Tanabe K, Tanimoto S, Hara K. Intravascular ultrasound-guided chronic total occlusion wiring technique using 6 Fr catheters via bilateral transradial approach. Cardiovasc Interv Ther. 2015;30(1):68–71. https://doi.org/10.1007/s12928-014-0251-y.
Lee UJ, Kim HS, Lee C, Kim KY, Kim W. Thrombotic occlusion during intravascular ultrasonography-guided percutaneous coronary intervention of stumpless chronic total occlusion. Chonnam Med J. 2014;50(3):112–4. https://doi.org/10.4068/cmj.2014.50.3.112.
Brilakis ES. Manual of chronic total occlusion interventions a step-by-step approach. Second ed. London: Elsevier/Academic Press; 2018.
Dash D, Li L. Intravascular ultrasound guided percutaneous coronary intervention for chronic total occlusion. Curr Cardiol Rev. 2015;11:323–327
Lim MC. Antegrade techniques for chronic total occlusions. Curr Cardiol Rev. 2015;11:285–90.
Chou RH, Lai CH, Lu TM. Side-branch and coaxial intravascular ultrasound guided wire re-entry after failed retrograde approach of chronic total occlusion intervention. Acta Cardiol Sin. 2016;32(3):363–6.
Huang WC, Teng HI, Hsueh CH, Lin SJ, Chan WL, Lu TM. Intravascular ultrasound guided wiring re-entry technique for complex chronic total occlusions. J Interv Cardiol. 2018;31:572–9. https://doi.org/10.1111/joic.12518.
Christopoulos G, Wyman RM, Alaswad K, Karmpaliotis D, Lombardi W, Grantham JA, et al. Clinical utility of the Japan-chronic total occlusion score in coronary chronic total occlusion interventions: results from a multicenter registry. Circ Cardiovasc Interv. 2015;8(7):e002171. https://doi.org/10.1161/circinterventions.114.002171.
Matsuno S, Tsuchikane E, Harding SA, Wu EB, Kao HL, Brilakis ES, et al. Overview and proposed terminology for the reverse controlled antegrade and retrograde tracking (reverse CART) techniques. EuroIntervention. 2018;14(1):94–101. https://doi.org/10.4244/eij-d-17-00867.
• Dai J, Katoh O, Kyo E, Tsuji T, Watanabe S, Ohya H. Approach for chronic total occlusion with intravascular ultrasound-guided reverse controlled antegrade and retrograde tracking technique: single center experience. J Interv Cardiol. 2013;26(5):434–43. https://doi.org/10.1111/joic.12066 This paper showed that IVUS-guided reverse CART can be an effective strategy in patients with previoulsy failed antegrade or/and retrograde approach.
Kubo T, Akasaka T, Shite J, Suzuki T, Uemura S, Yu B, et al. OCT compared with IVUS in a coronary lesion assessment: the OPUS-CLASS study. J Am Coll Cardiol Img. 2013;6(10):1095–104. https://doi.org/10.1016/j.jcmg.2013.04.014.
Madder RD. Optical coherence tomography: the next ACE in CTO interventions? Cardiovasc Revasc Med. 2016;17(7):429–30. https://doi.org/10.1016/j.carrev.2016.09.006.
Jaguszewski M, Guagliumi G, Landmesser U. Optical frequency domain imaging for guidance of optimal stenting in the setting of recanalization of chronic total occlusion. J Invasive Cardiol. 2013;25(7):367–8.
Galassi R, Burini A, Ricci S, Pellei M, Rigobello MP, Citta A, et al. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents. Dalton Trans. 2012;41(17):5307–18. https://doi.org/10.1039/c2dt11781a.
Teijeiro Mestre R, Alegria-Barrero E, Di Mario C. Microchannels in recent chronic total occlusions assessed with frequency-domain optical coherence tomography. Rev Esp Cardiol (English ed). 2013;66(11):907. https://doi.org/10.1016/j.rec.2012.01.018.
• Heeger CH, Busjahn A, Hildebrand L, Fenski M, Lesche F, Meincke F, et al. Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry. EuroIntervention. 2016;11(9):1004–12. https://doi.org/10.4244/eijy14m10_01 This OCT study demonstrated significantly delayed DES coverage after CTO PCI vs PCI of non-CTO lesions.
Jia H, Hu S, Liu H, Zhu Y, Zhe CY, Li L, et al. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation. Catheter Cardiovasc Interv. 2017;89(S1):582–91. https://doi.org/10.1002/ccd.26969.
Sherbet DP, Christopoulos G, Karatasakis A, Danek BA, Kotsia A, Navara R, et al. Optical coherence tomography findings after chronic total occlusion interventions: insights from the “angiographic evaluation of the everolimus-eluting stent in chronic total occlusions” (ACE-CTO) study (NCT01012869). Cardiovasc Revasc Med. 2016;17(7):444–9. https://doi.org/10.1016/j.carrev.2016.04.002.
Vaquerizo B, Barros A, Pujadas S, Bajo E, Estrada D, Miranda-Guardiola F, et al. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study. EuroIntervention. 2015;11(5):555–63. https://doi.org/10.4244/eijy14m12_07.
Lesiak M, Lanocha M, Araszkiewicz A, Siniawski A, Grygier M, Pyda M, et al. Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry. EuroIntervention. 2016;12(2):e144–51. https://doi.org/10.4244/eijv12i2a27.
Mitomo S, Naganuma T, Fujino Y, Kawamoto H, Basavarajaiah S, Pitt M, et al. Bioresorbable vascular scaffolds for the treatment of chronic total occlusions: an international multicenter registry. Circ Cardiovasc Interv. 2017;10(1). https://doi.org/10.1161/circinterventions.116.004265.
Fam JM, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, et al. Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions. EuroIntervention. 2017;13(3):355–63. https://doi.org/10.4244/eij-d-16-00253.
Ozel E, Tastan A, Ozturk A, Ozcan EE, Kilicaslan B, Ozdogan O. Procedural and one-year clinical outcomes of bioresorbable vascular scaffolds for the treatment of chronic total occlusions: a single-centre experience. Cardiovasc J Afr. 2016;27(6):345–9. https://doi.org/10.5830/cvja-2016-033.
Vaquerizo B, Barros A, Pujadas S, Bajo E, Jimenez M, Gomez-Lara J, et al. One-year results of bioresorbable vascular scaffolds for coronary chronic total occlusions. Am J Cardiol. 2016;117(6):906–17. https://doi.org/10.1016/j.amjcard.2015.12.025.
Biscaglia S, Secco GG, Tumscitz C, Di Mario C, Campo G. Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system. Int J Cardiol. 2015;182:1–3. https://doi.org/10.1016/j.ijcard.2014.12.103.
Li H, Rha SW, Choi CU, Oh DJ. Optical coherence tomography and stent boost imaging guided bioresorbable vascular scaffold overlapping for coronary chronic total occlusion lesion. Yonsei Med J. 2017;58(5):1071–4. https://doi.org/10.3349/ymj.2017.58.5.1071.
La Manna A, Micciche E, D'Agosta G, Tensol Rodrigues Pereira G, Attizzani GF, Capranzano P, et al. Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a one-year optical coherence tomography analysis from the GHOST-CTO registry. Int J Cardiol. 2018;253:45–9. https://doi.org/10.1016/j.ijcard.2017.10.107.
Okamura A, Yamane M, Muto M, Matsubara T, Igarashi Y, Nakamura S, et al. Complications during retrograde approach for chronic coronary total occlusion: sub-analysis of Japanese multicenter registry. Catheter Cardiovasc Interv. 2016;88(1):7–14. https://doi.org/10.1002/ccd.26317.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Karmpaliotis reports speaker honoraria from Abbott Vascular, Boston Scientific, Medtronic, and Vascular Solutions.
Dr. Garbo is a consultant for Philips Volcano Europe.
Dr. Burke is a consultant for Abbott Vascular and Boston Scientific.
Dr. Brilakis reports consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, and Medtronic; research support from Siemens, Regeneron, and Osprey. Shareholder: MHI Ventures. Board of Trustees: Society of Cardiovascular Angiography and Interventions.
All other authors declare no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Intravascular Imaging
Rights and permissions
About this article
Cite this article
Xenogiannis, I., Tajti, P., Karmpaliotis, D. et al. Intravascular Imaging for Chronic Total Occlusion Intervention. Curr Cardiovasc Imaging Rep 11, 31 (2018). https://doi.org/10.1007/s12410-018-9471-3
Published:
DOI: https://doi.org/10.1007/s12410-018-9471-3